IL10 and Epstein-Barr virus infection: In EBV infections, viral IL-10 (vIL-10; BCRF1) acts as an anti-inflammatory cytokine, reduces the cytotoxic activity of natural killer (NK) cells, and impairs adaptive immunity [62,63,64].